Advertisement
U.S. Markets open in 7 hrs 44 mins
S&P Futures
6,004.75 +1.00 (+0.02%) Dow Futures
43,907.00 -3.00 (-0.01%) Nasdaq Futures
21,230.75 +6.00 (+0.03%) Russell 2000 Futures
2,396.70 +1.00 (+0.04%) Crude Oil
71.73 -0.63 (-0.87%) Gold
2,694.50 -11.30 (-0.42%)
Scancell Holdings plc (SCLP.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Follow
At close: 02:45PM GMT
| Previous Close | 13.38 |
| Open | 12.92 |
| Bid | 12.75 x 0 |
| Ask | 14.00 x 0 |
| Day's Range | 12.75 - 14.00 |
| 52 Week Range | 8.60 - 19.75 |
| Volume | |
| Avg. Volume | 797,001 |
| Market Cap | 124.334M |
| Beta (5Y Monthly) | 0.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 |
| Earnings Date | Jan 28, 2025 - Feb 03, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.15 |
Medical Device NetworkPharmaJet signs deal with Scancell for needle-free melanoma vaccine
Scancell is responsible for the clinical and regulatory development, as well as commercialisation of the combined product.
Simply Wall St.Hedge funds investors control 42% of Scancell Holdings plc (LON:SCLP) and were rewarded last week after stock increased 13%
Key Insights Institutions' substantial holdings in Scancell Holdings implies that they have significant influence over...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.